Serial Number | 79311087 |
Word Mark | NOVOTECH HEALTH |
Filing Date | Monday, October 26, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, February 15, 2022 |
Registration Number | 6641668 |
Registration Date | Tuesday, February 15, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 30, 2021 |
Disclaimer with Predetermined Text | "HEALTH" |
Goods and Services | conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others [scientific research]; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statistics, namely, scientific analysis in the field of clinical trial results for scientific research; preparation of biostatistics, namely, scientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trials, namely, providing medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards, namely, preparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 21, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Novotech (Australia) Pty Ltd |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | AU |
Party Name | Novotech (Australia) Pty Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | AU |
Party Name | Novotech (Australia) Pty Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | AU |
Event Date | Event Description |
Tuesday, August 16, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, July 22, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, July 22, 2022 | FINAL DISPOSITION PROCESSED |
Sunday, May 15, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, February 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
Monday, December 6, 2021 | NOTIFICATION PROCESSED BY IB |
Tuesday, November 30, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 30, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, November 17, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, November 17, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, November 10, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, October 28, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, October 28, 2021 | EXAMINER'S AMENDMENT ENTERED |
Thursday, October 28, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, October 28, 2021 | EXAMINERS AMENDMENT E-MAILED |
Thursday, October 28, 2021 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, September 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, September 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, September 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, June 28, 2021 | REFUSAL PROCESSED BY IB |
Thursday, June 10, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, June 10, 2021 | REFUSAL PROCESSED BY MPU |
Wednesday, June 9, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, June 8, 2021 | NON-FINAL ACTION WRITTEN |
Tuesday, May 25, 2021 | APPLICATION FILING RECEIPT MAILED |
Friday, May 21, 2021 | ASSIGNED TO EXAMINER |
Friday, May 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, May 20, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |